The Effect of Placement of Proseal Laryngeal Mask Airway With C-Mac Videolaryngoscopy

Sponsor
Inonu University (Other)
Overall Status
Completed
CT.gov ID
NCT03852589
Collaborator
(none)
115
1
2
1
112.9

Study Details

Study Description

Brief Summary

The ProSeal laryngeal mask airway (ProSeal LMA; Intavent Orthofix, Maidenhead, UK) is a device with a double cuff to improve the seal and a drain tube to help prevent aspiration and gastric insufflation, facilitate passage of a gastric tube, and provide information about malposition. The manufacturer recommends inserting the ProSealTM LMA using digital manipulation or with an introducer tool, but both these techniques have lower success rates than the classic LMA.

This prospective study that will investigated the usefulness of the C-MAC videolaryngoscopy for inserting a PLMA in anesthetized non-paralyzed patients and compared it with the index finger.

Condition or Disease Intervention/Treatment Phase
  • Device: C-MAC videolaryngoscope
  • Device: Blind
N/A

Detailed Description

Airway management is one of the cornerstones for modern anaesthesia and is vital for all patients undergoing general anaesthesia. Supraglottic airway devices (SADs) are increasingly used for managing airways.

The ProSeal laryngeal mask airway (PLMA) (Laryngeal Mask Company, San Diego, CA, USA) is a supraglottic airway device with a larger cuff than the Classic laryngeal mask airway to produce a better seal. The PLMA is also equipped with a drainage tube to permit insertion of a gastric tube and evacuation of gastric content. The presence of the drainage tube reduces the risk of aspiration, which is the major concern of the Classic laryngeal mask airway, especially when the device is used with positive pressure ventilation. While a dedicated introducer (commonly known as an ''introducer tool'') is recommended by the manufacturer to facilitate insertion of the PLMA, difficulties can still be encountered during insertion. The PLMA insertion success rate at first attempt has been reported as 82-87%, which is lower than the insertion success rate of the Classic laryngeal mask airway.

Malpositioning of the PLMA is common in clinical practice because its soft cuff can fold over onto itself. Malpositioning of the device can result in severe leaks and even obstruction of the airway, with potentially negative outcomes for the patient. Although the incidence of complications(e.g. airway trauma, obstruction, regurgitation, gastric distension with mechanical ventilation) is likely to be higher with an incorrectly placed SAD, clinical airway obstruction can result from other causes, such as laryngospasm and transient closure of the glottis.

Many methods have been proposed to facilitate insertion of PLMAs, including insertion of a gastric tube,a suction catheter, or a gum elastic bougie into the drainage tube. These techniques help to prevent the PLMA soft cuff from folding over and help to decrease the incidence of malpositioning.

This prospective study that will investigated the usefulness of the C-MAC videolaryngoscopy for inserting a PLMA in anesthetized non-paralyzed patients and compared it with the index finger.

Study Design

Study Type:
Interventional
Actual Enrollment :
115 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Screening
Official Title:
Comparison of C-MAC Videolaryngoscopy-guided Proseal Laryngeal Mask Airway Placement vs Conventional Blind Technique: a Prospective Randomized Study
Actual Study Start Date :
Mar 1, 2019
Actual Primary Completion Date :
Apr 1, 2019
Actual Study Completion Date :
Apr 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: C-MAC Videolaryngoscope

C-MAC Videolaryngoscope: An intubating device that is used for endotracheal intubation. Proseal laryngeal mask airway will be inserted with C-MAC Videolaryngoscope

Device: C-MAC videolaryngoscope
An intubating device that is used for endotracheal intubation. PLMA will inserted by anesthesiologist with C-MAC videolaryngoscope.

Active Comparator: Blind

Proseal laryngeal mask airway will be inserted with digital finger

Device: Blind
PLMA will inserted by anesthesiologist with digital finger.

Outcome Measures

Primary Outcome Measures

  1. First attempt success rate [From inserted PLMA to seeing meaningful end-tidal carbon dioxide levels up to 2 minutes]

    The PLMA will inserted into hypopharynx, the cuff will inflated with an appropraite volume of air. An effective airway will judged by a square wave on capnography.

Secondary Outcome Measures

  1. Insertion time [From inserted PLMA to seeing two meaningful end-tidal carbon dioxide levels up to 3 minutes]

    Insertion time was the time between picking up the PLMA and successful placement

  2. Adverse Events [During the first 24 hour postoperatively]

    Blood on the surface of the cuff, laryngospasm, hypoxia, hoarseness,sore throat

  3. Fiberoptic Score [After the PLMA insertion up to 5 minutes]

    Fiberoptic view of PLMA placement through the airway tube was graded on a scale from 4 (best view) to 1 (worst view)

  4. Airway Sealing Pressure [After the PLMA insertion up to 5 minutes]

    Fresh gas flow was adjusted to 3 L/min, and after closing the expiratory valve, the airway pressure at which an audible leak in the mouth was heard will recorded

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18- 65 years

  • Undergoing short surgical prcedures with general anesthesia using a PLMA

  • American Society of Anesthesiology score I-II

Exclusion Criteria:
  • Anticipated difficult airway

  • Risk of aspiration

  • Patients who refused written informed consent forms

Contacts and Locations

Locations

Site City State Country Postal Code
1 Inonu University Malatya Turkey 44090

Sponsors and Collaborators

  • Inonu University

Investigators

  • Principal Investigator: Ulku Ozgul, Inonu University Faculty of Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Ülkü Özgül, Associate professor, Inonu University
ClinicalTrials.gov Identifier:
NCT03852589
Other Study ID Numbers:
  • UlkuVL
First Posted:
Feb 25, 2019
Last Update Posted:
Apr 9, 2019
Last Verified:
Apr 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ülkü Özgül, Associate professor, Inonu University

Study Results

No Results Posted as of Apr 9, 2019